Ben Vollrath talks about his job at Amprion as its COO, and what it means to be a scientist.
Meet Amprion’s COO, Ben Vollrath
We’re trying to solve a dire lack of treatments that are available for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. And the field has really been inhibited by the lack of tools to identify patient populations that would respond to certain treatments. And we believe we’ve solved this problem. We believe we have a tool that will enable the entire field and allow for the development of new treatments.
There’s millions of people who suffer from Alzheimer’s disease, it’s a terrible disease. There are really no treatment options available. And I think it’s critical that we develop something new, and we’re providing a key piece of this puzzle. What makes me tick as a senior scientist, it’s just you know discovery is fun, and you know we’re basically exploring something that nobody’s ever done before. And while making what I think is an important contribution to solving this big problem.
Related Posts on Early Detection of Alzheimer’s and Parkinson’s:
- Early Detection is Key to Preventive Brain Care
- Early Detection of Biomarkers For Alzheimer’s and Parkinson’s
- The Amprion Story | Early Detection for Alzheimer’s & Parkinson’s
- Protein Misfolding in Neurodegenerative Brain Diseases: The Key Questions